NeuroMetrix, Inc. (NASDAQ:NURO)

CAPS Rating: No stars

The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.

Recs

0
Player Avatar brightidea2006 (51.24) Submitted: 10/20/2006 11:44:15 AM : Outperform Start Price: $19.57 NURO Score: -98.76

great clinical adoption of neuro test and short thesis of reimbursement cuts way overplayed

Featured Broker Partners


Advertisement